Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Toxin synergism is a complex biochemical phenomenon, where different animal venom proteins interact either directly or indirectly to potentiate toxicity to a level that is above the sum of the toxicities of the individual toxins. This provides the animals possessing venoms with synergistically enhanced toxicity with a metabolic advantage, since less venom is needed to inflict potent toxic effects in prey and predators. Among the toxins that are known for interacting synergistically are cytotoxins from snake venoms, phospholipases A2 from snake and bee venoms, and melittin from bee venom. These toxins may derive a synergistically enhanced toxicity via formation of toxin complexes by hetero-oligomerization. Using a human keratinocyte assay mimicking human epidermis in vitro, we demonstrate and quantify the level of synergistically enhanced toxicity for twelve cytotoxin/melittin-PLA2 combinations using toxins from elapids, vipers, and bees. Moreover, by utilizing an interaction-based assay and by conducting a thorough literature review, we speculate and propose a mechanistic model for how toxin synergism in relation to cytotoxicity may be mediated by cytotoxin/melittin and PLA2 complex formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Phospholipase A2 structure/function, mechanism, and signaling
Burke, J. E., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800033-jlr200 · Cited by 933
Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development
Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C. (2017) · BioMed Research International · doi:10.1155/2017/6592820 · Cited by 113 · cited 2×
“Catalytically active svPLA2s hydrolyze membrane glycerophospholipids at the sn-2 site of these molecules (Xiao et al., 2017), however, many svPLA2s have over the course of evolution lost their catalytic activity, yet retain toxicity via other functions, such as an ability to disrupt cellular…”
BackgroundSynergistic strategies of predominant toxins in snake venoms
Xiong, S., & Huang, C. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.004 · Cited by 78
Toxin synergism in snake venoms
Laustsen, A. H. (2016) · Toxin Reviews · doi:10.1080/15569543.2016.1220397 · Cited by 65 · cited 3×
“This metabolic cost has forced venomous animals to evolve mechanisms for minimizing venom expenditure, such as the venom optimization hypothesis (Wigger et al., 2002) and toxin synergism (Laustsen, 2016).”
BackgroundSelf-citation
Cited by
Bittenbinder, M. A., van Thiel, J., Cardoso, F. C., Casewell, N. R., Gutiérrez, J.-M., Kool, J., & Vonk, F. J. (2024) · Communications Biology · doi:10.1038/s42003-024-06019-6 · Cited by 132
Senji Laxme, R. R., Attarde, S., Khochare, S., Suranse, V., Martin, G., Casewell, N. R., Whitaker, R., & Sunagar, K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009150 · Cited by 101
“Snake venom is a concoction of diverse biochemical components that often work synergistically to facilitate effective prey capture [79,89–91].”
Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Bartlett, K. E., Westhorpe, A. P., Albulescu, L.-O., Kool, J., Gutiérrez, J. M., & Casewell, N. R. (2023) · Nature Communications · doi:10.1038/s41467-023-43510-w · Cited by 63
Kalita, B., Utkin, Y. N., & Mukherjee, A. K. (2022) · Toxins · doi:10.3390/toxins14120839 · Cited by 50
“mossa bica occurs via the format on of toxin hetero-oligomers that a e better poised to interact with and perturb cell membranes [73].”
Background
Metadata
- Authors
- Pucca, M. B., Ahmadi, S., Cerni, F. A., Ledsgaard, L., Sørensen, C. V., McGeoghan, F. T. S., Stewart, T., Schoof, E., Lomonte, B., auf dem Keller, U., Arantes, E. C., Çalışkan, F., & Laustsen, A. H.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-07
- Volume
- 11
- Pages
- 611-611
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3022941046
- Cited by
- 50
- References
- 5
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.